Impact of pathologic re-review on grade, clinical stage, and risk stratification for patients with nonmuscle invasive bladder cancer.
Campbell RA, Wood A, Michael PD, Shin D, Pramod N, Haywood SC, Eltemamy M, Weight C, Haber GP, Lee B, Myles J, McKenney J, Nguyen J, Williamson SR, Przybycin C, Alaghehbandan R, Almassi N.
Campbell RA, et al. Among authors: michael pd.
Urol Oncol. 2024 Nov;42(11):372.e21-372.e27. doi: 10.1016/j.urolonc.2024.05.020. Epub 2024 Jun 15.
Urol Oncol. 2024.
PMID: 38880703
Free article.